rs531081279

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6BS1BS2

The NM_022051.3(EGLN1):​c.319G>T​(p.Ala107Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,308,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A107G) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.000040 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000039 ( 0 hom. )

Consequence

EGLN1
NM_022051.3 missense

Scores

1
16

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:1

Conservation

PhyloP100: 0.0340

Publications

0 publications found
Variant links:
Genes affected
EGLN1 (HGNC:1232): (egl-9 family hypoxia inducible factor 1) The protein encoded by this gene catalyzes the post-translational formation of 4-hydroxyproline in hypoxia-inducible factor (HIF) alpha proteins. HIF is a transcriptional complex that plays a central role in mammalian oxygen homeostasis. This protein functions as a cellular oxygen sensor, and under normal oxygen concentration, modification by prolyl hydroxylation is a key regulatory event that targets HIF subunits for proteasomal destruction via the von Hippel-Lindau ubiquitylation complex. Mutations in this gene are associated with erythrocytosis familial type 3 (ECYT3). [provided by RefSeq, Nov 2009]
EGLN1 Gene-Disease associations (from GenCC):
  • erythrocytosis, familial, 3
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Genomics England PanelApp
  • autosomal dominant secondary polycythemia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hemoglobin, high altitude adaptation
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
  • hereditary pheochromocytoma-paraganglioma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.032389164).
BP6
Variant 1-231421570-C-A is Benign according to our data. Variant chr1-231421570-C-A is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 241416.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.0000395 (6/151834) while in subpopulation EAS AF = 0.00117 (6/5128). AF 95% confidence interval is 0.000509. There are 0 homozygotes in GnomAd4. There are 4 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High AC in GnomAd4 at 6 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_022051.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGLN1
NM_022051.3
MANE Select
c.319G>Tp.Ala107Ser
missense
Exon 1 of 5NP_071334.1R4SCQ0
EGLN1
NM_001377260.1
c.319G>Tp.Ala107Ser
missense
Exon 1 of 4NP_001364189.1
EGLN1
NM_001377261.1
c.319G>Tp.Ala107Ser
missense
Exon 1 of 4NP_001364190.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EGLN1
ENST00000366641.4
TSL:1 MANE Select
c.319G>Tp.Ala107Ser
missense
Exon 1 of 5ENSP00000355601.3Q9GZT9-1
ENSG00000287856
ENST00000662216.1
c.30+40868G>T
intron
N/AENSP00000499467.1A0A590UJK7
EGLN1
ENST00000889867.1
c.319G>Tp.Ala107Ser
missense
Exon 1 of 6ENSP00000559926.1

Frequencies

GnomAD3 genomes
AF:
0.0000395
AC:
6
AN:
151726
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00117
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD4 exome
AF:
0.0000389
AC:
45
AN:
1156822
Hom.:
0
Cov.:
31
AF XY:
0.0000323
AC XY:
18
AN XY:
557508
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
22962
American (AMR)
AF:
0.00
AC:
0
AN:
8464
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
15138
East Asian (EAS)
AF:
0.00163
AC:
43
AN:
26458
South Asian (SAS)
AF:
0.00
AC:
0
AN:
35664
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
30116
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
3206
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
967922
Other (OTH)
AF:
0.0000427
AC:
2
AN:
46892
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.508
Heterozygous variant carriers
0
4
9
13
18
22
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0000395
AC:
6
AN:
151834
Hom.:
0
Cov.:
32
AF XY:
0.0000539
AC XY:
4
AN XY:
74228
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
41498
American (AMR)
AF:
0.00
AC:
0
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3464
East Asian (EAS)
AF:
0.00117
AC:
6
AN:
5128
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4828
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10474
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67868
Other (OTH)
AF:
0.00
AC:
0
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.442
Heterozygous variant carriers
0
1
2
2
3
4
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000416

ClinVar

ClinVar submissions as Germline
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Erythrocytosis, familial, 3 (1)
-
1
-
Hemoglobin, high altitude adaptation;C1853286:Erythrocytosis, familial, 3 (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.081
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.48
CADD
Benign
9.6
DANN
Benign
0.97
DEOGEN2
Benign
0.19
T
Eigen
Benign
-1.1
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.14
N
LIST_S2
Benign
0.41
T
MetaRNN
Benign
0.032
T
MetaSVM
Benign
-0.80
T
MutationAssessor
Benign
0.90
L
PhyloP100
0.034
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
0.37
N
REVEL
Benign
0.085
Sift
Benign
0.77
T
Sift4G
Benign
0.69
T
Polyphen
0.050
B
Vest4
0.071
MutPred
0.18
Gain of glycosylation at A107 (P = 0.007)
MVP
0.56
MPC
1.7
ClinPred
0.089
T
GERP RS
1.2
PromoterAI
-0.029
Neutral
Varity_R
0.069
gMVP
0.21
Mutation Taster
=93/7
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs531081279; hg19: chr1-231557316; API